Defining treatment aims and end-points in older patients with cancer

Affiliations

Review

C E Desch et al. Drugs Aging. 1995 May.

. 1995 May;6(5):351-7.

doi: 10.2165/00002512-199506050-00002.

¹ Department of Medicine, Massey Cancer Center, Virginia Commonwealth University/Medical College of Virginia, Richmond, USA.

No abstract available

Similar articles

Cancer chemotherapy in elderly cancer patients.
Balducci L. Balducci L. J Oncol Manag. 2005 Spring;14(2):35-8. J Oncol Manag. 2005. PMID: 16018197
Patient-reported outcomes as end points and outcome indicators in solid tumours.
Secord AA, Coleman RL, Havrilesky LJ, Abernethy AP, Samsa GP, Cella D. Secord AA, et al. Nat Rev Clin Oncol. 2015 Jun;12(6):358-70. doi: 10.1038/nrclinonc.2015.29. Epub 2015 Mar 10. Nat Rev Clin Oncol. 2015. PMID: 25754949 Review.
Survival and Participation in a Cancer Clinical Trial: A Provocative Relationship.
Markman M. Markman M. Oncology. 2016;91(4):177-178. doi: 10.1159/000448192. Epub 2016 Aug 25. Oncology. 2016. PMID: 27560780 No abstract available.
The changing picture of cancer.
Corner J. Corner J. Eur J Oncol Nurs. 2008 Sep;12(4):281-2. doi: 10.1016/j.ejon.2008.07.002. Eur J Oncol Nurs. 2008. PMID: 18765209 No abstract available.
Long-term Toxicity of Cancer Treatment in Older Patients.
Shahrokni A, Wu AJ, Carter J, Lichtman SM. Shahrokni A, et al. Clin Geriatr Med. 2016 Feb;32(1):63-80. doi: 10.1016/j.cger.2015.08.005. Epub 2015 Oct 13. Clin Geriatr Med. 2016. PMID: 26614861 Free PMC article. Review.